Summer Sale

Up to 30% off — ends 7 Aug

ONLY00h00m00s

Get 30% Off

Up to 30% off — ends 7 Aug

ONLY00h00m00s

Maiken Cavling Arendrup

Prof

University of Copenhagen

Denmark

This profile is automatically generated from trusted academic sources.

Google Scholar

ORCID

How do I reach out?

Meet Kite AI

Contact this professor

ORCID

Google Scholar

Research Interests

Microbiology

100%

Pharmacology

60%

Antifungal Therapy

100%

Antifungal Resistance

80%

Antimicrobial Research

70%

Fungal Pathology

60%

Fungal Biology

40%

Ask ApplyKite AI

Start chatting

How can you help me contact this professor?

What are this professor's research interests?

How should I write an email to this professor?

Articles23

Methylene blue photodynamic therapy of antifungal-unresponsive (resistant) dermatophytosis

Article Link

Year:

2025

How to interpret MICs of amphotericin B, echinocandins and flucytosine against Candida auris (Candidozyma auris) according to the newly established EUCAST breakpoints

Article Link

Year:

2025

A multicentre study for determination of epidemiological cut-off values for Candida auris with EUCAST broth microdilution reference methodology

Article Link

Year:

2025

EUCAST olorofim MICs for 3,550 Danish mold and dermatophyte isolates from 2020 to 2023

Article Link

Year:

2025

Refractory versus resistant invasive aspergillosis

Article Link

Year:

2025

Novel antifungals and treatment approaches to tackle resistance and improve outcomes of invasive fungal disease

Article Link

Year:

2024

Comparative pharmacodynamics and dose optimization of liposomal amphotericin B against Candida species in an in vitro pharmacokinetic/pharmacodynamic model

Article Link

Year:

2024

Twenty Years in EUCAST Anti-Fungal Susceptibility Testing: Progress & Remaining Challenges

Article Link

Year:

2024

Reply to Kidd et al., “Inconsistencies within the proposed framework for stabilizing fungal nomenclature risk further confusion”

Article Link

Year:

2024

Development of an agar-based screening method for terbinafine, itraconazole, and amorolfine susceptibility testing of Trichophyton spp.

Article Link

Year:

2024

Nomenclature for human and animal fungal pathogens and diseases: a proposal for standardized terminology

Article Link

Year:

2024

A Practical Guide to Antifungal Susceptibility Testing.

Article Link

Year:

2023

Development of an in vitro pharmacokinetic/pharmacodynamic model in the presence of serum for studying micafungin activity against Candida albicans: a need for revision of CLSI susceptibility breakpoints

Article Link

Year:

2023

Development and preliminary validation of a modified EUCAST yeast broth microdilution MIC method with Tween 20-supplemented medium for rezafungin

Article Link

Year:

2023

Multicentre validation of a modified EUCAST MIC testing method and development of associated epidemiologic cut-off (ECOFF) values for rezafungin

Article Link

Year:

2023

A conceptual framework for nomenclatural stability and validity of medically important fungi: a proposed global consensus guideline for fungal name changes supported by ABP, ASM, CLSI, ECMM, ESCMID-EFISG, EUCAST-AFST, FDLC, IDSA, ISHAM, MMSA, and MSGERC

Article Link

Year:

2023

Invasive Aspergillosis among Lung Transplant Recipients during Time Periods with Universal and Targeted Antifungal Prophylaxis—A Nationwide Cohort Study

Article Link

Year:

2023

Adverse Events Associated with Universal versus Targeted Antifungal Prophylaxis among Lung Transplant Recipients—A Nationwide Cohort Study 2010–2019

Article Link

Year:

2022

EUCAST Ibrexafungerp MICs and Wild-Type Upper Limits for Contemporary Danish Yeast Isolates

Article Link

Year:

2022

Pan-Echinocandin Resistant C. parapsilosis Harboring an F652S Fks1 Alteration in a Patient with Prolonged Echinocandin Therapy

Article Link

Year:

2022

Correction: Astvad et al. Increasing Terbinafine Resistance in Danish Trichophyton Isolates 2019–2020. J. Fungi 2022, 8, 150

Article Link

Year:

2022

Molecular mechanisms of acquired antifungal drug resistance in principal fungal pathogens and EUCAST guidance for their laboratory detection and clinical implications

Article Link

Year:

2022

Disinfection trials with terbinafine‐susceptible and terbinafine‐resistant dermatophytes

Article Link

Year:

2022

Collaborators16

Iraklis Tsangaris

University General Hospital Attikon

GREECE

Ditte M. L. Saunte

DENMARK

Brian Fisher

Associate Professor of Pediatrics and Epidemiology

Children's Hospital of Philadelphia

UNITED STATES

Martin Hoenigl

Associate Professor for Translational Mycology

Medical University of Graz

AUSTRIA

S. M. Leal

The University of Alabama

UNITED STATES

Sarah Sedik

Medical University of Graz

AUSTRIA

Pernille Lindsø Andersen

Zealand University Hospital

DENMARK

Joseph Meletiadis

GREECE

Agostinho Carvalho

University of Minho

PORTUGAL

Matthias Egger

Medical University of Graz

AUSTRIA

michael perch

Associate Clinical Professor

University of Copenhagen

DENMARK

Thomas R. Rogers

Trinity College Dublin

IRELAND

George R. Thompson

UNITED STATES

Jochem Buil

Radboud University Medical Center

NETHERLANDS

Jeffrey Jenks

Adjunct Associate Professor of Medicine

Duke University

UNITED STATES

Jesús Guinea

Universidad Complutense de Madrid

SPAIN

How do I reach out?

Meet Kite AI